Gerresheimer AG Logo

Gerresheimer AG

Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.

GXI | F

Overview

Corporate Details

ISIN(s):
DE000A0LD6E6
LEI:
5299006GD4UWSYZOKC28
Country:
Germany
Address:
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 09:46
Declaration of Voting Results & Voting Rights Announcements
English 13.9 KB
2025-11-20 13:18
Board/Management Information
Gerresheimer AG: Change in the Supervisory Board
English 9.3 KB
2025-11-19 18:38
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-18 10:02
Environmental & Social Information
Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
English 13.3 KB
2025-11-17 17:11
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-11-12 18:26
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-10 16:10
Declaration of Voting Results & Voting Rights Announcements
English 16.8 KB
2025-11-06 11:32
Declaration of Voting Results & Voting Rights Announcements
English 14.3 KB
2025-11-03 11:36
Declaration of Voting Results & Voting Rights Announcements
English 16.3 KB
2025-10-31 11:32
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-30 10:54
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-29 10:40
Declaration of Voting Results & Voting Rights Announcements
English 16.0 KB
2025-10-28 16:10
Board/Management Information
Gerresheimer: Uwe Rohrhoff takes over as interim CEO for Dietmar Siemssen
English 10.5 KB
2025-10-27 10:05
Declaration of Voting Results & Voting Rights Announcements
English 14.9 KB
2025-10-25 19:24
Legal Proceedings Report
Gerresheimer AG: Initial findings of an external independent investigation into…
English 7.9 KB

Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gerresheimer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gerresheimer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Siemssen, Dietmar Board Buy None 74,994.10 EUR
2022-10-14 Siemssen, Dietmar Board Buy None 137,500.00 EUR
2022-10-14 Simon-Schröter, Dr Wolfram Other Buy None 2,958.00 EUR
2022-09-19 Abt, Andrea Supervisory board Buy None 25,075.00 EUR
2022-09-19 Empl, Andreas Board Buy None 1,820.00 EUR
2022-07-18 Siemssen, Dietmar Board Buy None 151,730.25 EUR
2021-07-14 Burkhardt, Dr. Lukas Board Buy None 181,357.60 EUR
2021-07-14 Siemssen, Dietmar Board Buy None 139,732.50 EUR

Peer Companies

CellaVision Logo
Provides digital microscopy solutions to automate blood analysis for global hematology labs.
Sweden
CEVI
Develops bone grafts, artificial joints, and enzymes for the biopharmaceutical sector.
South Korea
049180
CERUS CORP Logo
Develops pathogen reduction technology to safeguard the global blood supply for healthcare providers.
United States of America
CERS
CG MedTech Co.,Ltd. Logo
Develops & sells orthopedic implants & devices using advanced biomaterial technology.
South Korea
056090
C.I.MEDICAL CO.,LTD. Logo
Mail-order supplier of 60k+ dental/medical items, also developing proprietary care products.
Japan
3540
Colan Totte.Co.,Ltd. Logo
Medical-grade magnetic wearables improving circulation & relieving stiffness for athletes & consumers.
Japan
7792
Coloplast Logo
Develops medical devices and services for people with intimate healthcare needs.
Denmark
COLO
COLTENE Holding AG Logo
Develops and sells dental consumables and small equipment for dental professionals worldwide.
Switzerland
CLTN
Condor Technologies NV Logo
Develops and manufactures dental intra-oral scanners for precise digital impressions.
Belgium
MLMFI
CONMED Corp Logo
Develops surgical devices and equipment for orthopedic, general, and GI surgery.
United States of America
CNMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.